OBJECTIVE: To provide researchers an extensive characterization of the SPECTRUM variable nicotine research cigarettes. METHODS: Data on cigarette physical properties, nicotine content, harmful and potentially harmful constituents in the tobacco filler was compiled. RESULTS: Data on physical properties, concentrations of menthol, nicotine and minor alkaloids, tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, ammonia, and toxic metals in the filler tobacco for all available varieties of Spectrum research cigarettes are provided. The similarity in the chemistry and physical properties of SPECTRUM cigarettes to commercial cigarettes renders them acceptable for use in behavioral studies. Baseline information on harmful and potentially harmful constituents in research tobacco products, particularly constituent levels such as minor alkaloids that fall outside typical ranges reported for commercial, provide researchers with the opportunity to monitor smoking behavior and to identify biomarkers that will inform efforts to understand the role of nicotine in creating and sustaining addiction. CONCLUSIONS: Well characterized research cigarettes suitable for human consumption are an important tool in clinical studies for investigating the physiological impacts of cigarettes delivering various levels of nicotine, the impact of reduced nicotine cigarettes on nicotine addiction, and the relationship between nicotine dose and smoking behavior.
OBJECTIVE: To provide researchers an extensive characterization of the SPECTRUM variable nicotine research cigarettes. METHODS: Data on cigarette physical properties, nicotine content, harmful and potentially harmful constituents in the tobacco filler was compiled. RESULTS: Data on physical properties, concentrations of menthol, nicotine and minor alkaloids, tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, ammonia, and toxic metals in the filler tobacco for all available varieties of Spectrum research cigarettes are provided. The similarity in the chemistry and physical properties of SPECTRUM cigarettes to commercial cigarettes renders them acceptable for use in behavioral studies. Baseline information on harmful and potentially harmful constituents in research tobacco products, particularly constituent levels such as minor alkaloids that fall outside typical ranges reported for commercial, provide researchers with the opportunity to monitor smoking behavior and to identify biomarkers that will inform efforts to understand the role of nicotine in creating and sustaining addiction. CONCLUSIONS: Well characterized research cigarettes suitable for human consumption are an important tool in clinical studies for investigating the physiological impacts of cigarettes delivering various levels of nicotine, the impact of reduced nicotine cigarettes on nicotine addiction, and the relationship between nicotine dose and smoking behavior.
Authors: T A Chepiga; M J Morton; P A Murphy; J T Avalos; B R Bombick; D J Doolittle; M F Borgerding; J E Swauger Journal: Food Chem Toxicol Date: 2000-10 Impact factor: 6.023
Authors: R Steven Pappas; Naudia Martone; Nathalie Gonzalez-Jimenez; Mark R Fresquez; Clifford H Watson Journal: J Anal Toxicol Date: 2015-02-27 Impact factor: 3.367
Authors: Irina Stepanov; Aleksandar Knezevich; Liqin Zhang; Clifford H Watson; Dorothy K Hatsukami; Stephen S Hecht Journal: Tob Control Date: 2011-05-20 Impact factor: 7.552
Authors: Dorothy K Hatsukami; Stephen J Heishman; Rachel Isaksson Vogel; Rachel L Denlinger; Astia N Roper-Batker; Kristen M Mackowick; Joni Jensen; Sharon E Murphy; Brian F Thomas; Eric Donny Journal: Nicotine Tob Res Date: 2012-11-22 Impact factor: 4.244
Authors: E Roemer; T H Ottmueller; V Zenzen; S Wittke; F Radtke; I Blanco; R A Carchman Journal: Food Chem Toxicol Date: 2009-05-15 Impact factor: 6.023
Authors: Sam N Cwalina; Anuja Majmundar; Jennifer B Unger; Jessica L Barrington-Trimis; Mary Ann Pentz Journal: Drug Alcohol Depend Date: 2019-11-15 Impact factor: 4.492
Authors: J Foulds; A Hobkirk; E Wasserman; J Richie; S Veldheer; N M Krebs; L Reinhart; J Muscat Journal: Prev Med Date: 2018-04-04 Impact factor: 4.018
Authors: Mark R Fresquez; Nathalie Gonzalez-Jimenez; Naudia Gray; Liza Valentin-Blasini; Clifford H Watson; R Steven Pappas Journal: J Anal Toxicol Date: 2017-05-01 Impact factor: 3.367